AntoinetteMarieMoranMD

Pediatric Diabetes Endocrinology

Physician

Dr. Moran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2540 Riverside Ave
University Of Minnesota Dept of Pediatrics
Minneapolis, MN 55455
Phone+1 612-624-5409

PubMed

Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial.
Michele Schiavon, Claudio Cobelli, K Sreekumaran Nair, Katherine Klaus, Gianna Toffolo
Journal of Cystic Fibrosis. 2025-01-01
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review.
Ammar Ahmed, Anvitha Ankireddypalli, Tasma Harindhanavudhi, Antoinette Moran, Amir Moheet
Journal of Clinical & Translational Endocrinology. 2024-12-01
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
Alfonso Galderisi, Emily K Sims, Carmella Evans-Molina, Alessandra Petrelli, David Cuthbertson
Diabetologia. 2024-11-19

Journal Articles

An Increase in Chromogranin A-positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis
Robert A Rizza, Antoinette Moran, Journal of the Endocrine Society

Verapamil Shows Beneficial Effect on the Pancreas in Children with Newly-Diagnosed Type 1 DiabetesFebruary 25th, 2023
Research Brief: Verapamil Shows Beneficial Effect on the Pancreas in Children with Newly-Diagnosed Type 1 DiabetesFebruary 24th, 2023
Top Researchers Gather for the 17th ATTD ConferenceMarch 1st, 2024